Neuropsychiatric Disease and Treatment

Código QR

Neuropsychiatric Disease and Treatment

Guardado en:

Detalles Bibliográficos
Formato:	journal
Lenguaje:	EN
Publicado:	Dove Medical Press 2009
Materias:	neuropsychiatric disorders neurological disorders clinical neurology clinical neuropsychiatry Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/toc/1178-2021
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Chronic organophosphate-induced neuropsychiatric disorder: a case report
por: Ghimire SR, et al.
Publicado: (2016)

Neuropsychiatric symptoms in untreated Parkinson’s disease
por: Szatmari S, et al.
Publicado: (2017)

Letter to the Editor – Towards an Outpatient Model of Care for Motor Functional Neurological Disorders: A Neuropsychiatric Perspective [Letter]
por: de Vroege L, et al.
Publicado: (2021)

Contemplating stem cell therapy for epilepsy-induced neuropsychiatric symptoms
por: Rao G, et al.
Publicado: (2017)

Neuropsychiatric symptoms and celiac disease
por: Urban-Kowalczyk M, et al.
Publicado: (2014)

Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders
por: Diniz BS, et al.
Publicado: (2013)

Clinical feature and outcome of late-onset cobalamin C disease patients with neuropsychiatric presentations: a Chinese case series
por: Wang S, et al.
Publicado: (2019)

Behavior and neuropsychiatric manifestations in Angelman syndrome
por: Karine Pelc, et al.
Publicado: (2008)

Neuropsychological assessment, neuroimaging, and neuropsychiatric evaluation in pediatric and adult patients with sickle cell disease (SCD)
por: Christopher L Edwards, et al.
Publicado: (2007)

Diagnostic and treatment challenges in traumatic brain injury patients with severe neuropsychiatric symptoms: insights into psychiatric practice
por: Lauterbach MD, et al.
Publicado: (2015)

Towards an Outpatient Model of Care for Motor Functional Neurological Disorders: A Neuropsychiatric Perspective
por: Saxena A, et al.
Publicado: (2020)

Antiphospholipid syndrome presenting as progressive neuropsychiatric disorders: two case reports
por: Li CH, et al.
Publicado: (2013)

Genetic and epigenetic mechanisms of epilepsy: a review
por: Chen T, et al.
Publicado: (2017)

Acute neuropsychiatric disorders in adolescents and young adults with Down syndrome: Japanese case reports
por: Akahoshi K, et al.
Publicado: (2012)

22q11 deletion syndrome: a review of the neuropsychiatric features and their neurobiological basis
por: Squarcione C, et al.
Publicado: (2013)

Higher FKBP5, COMT, CHRNA5, and CRHR1 allele burdens are associated with PTSD and interact with trauma exposure: implications for neuropsychiatric research and treatment
por: Boscarino JA, et al.
Publicado: (2012)

Construction of standardized Arabic questionnaires for screening neurological disorders (dementia, stroke, epilepsy, movement disorders, muscle and neuromuscular junction disorders)
por: El Tallawy HN, et al.
Publicado: (2016)

Brain activity modification produced by a single radioelectric asymmetric brain stimulation pulse: a new tool for neuropsychiatric treatments. Preliminary fMRI study
por: Castagna A, et al.
Publicado: (2011)

Comparison of treatment outcomes in severe personality disorder patients with or without substance use disorders: a 36-month prospective pragmatic follow-up study
por: Lana F, et al.
Publicado: (2016)

19q12q13.2 duplication syndrome: neuropsychiatric long-term follow-up of a new case and literature update
por: Nacinovich R, et al.
Publicado: (2017)

Postulated vasoactive neuropeptide immunopathology affecting the blood&ndash;brain/blood&ndash;spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment?
por: Sonya Marshall-Gradisnik, et al.
Publicado: (2008)

Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761&reg;. Findings from a randomized controlled trial
por: Bachinskaya N, et al.
Publicado: (2011)

Continuous decrease in serum brain-derived neurotrophic factor (BDNF) levels in a neuropsychiatric syndrome of systemic lupus erythematosus patient with organic brain changes
por: Atsuko Ikenouchi-Sugita, et al.
Publicado: (2008)

Uncovering the etiology of conversion disorder: insights from functional neuroimaging
por: Ejareh dar M, et al.
Publicado: (2016)

Predictors of Neurological Presentations of COVID-19 Infected Patients in South Egypt, Aswan Governorate: A Single Center Study
por: Tony AA, et al.
Publicado: (2021)

Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization
por: Mar J, et al.
Publicado: (2019)

Psychiatrists’ Understanding and Management of Conversion Disorder: A Bi-National Survey and Comparison with Neurologists
por: Dent B, et al.
Publicado: (2020)

Erratum:&nbsp;An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatr Dis Treat, 4: 967&ndash;976
por: Colombo GL, et al.
Publicado: (2009)

Rasagiline in treatment of Parkinson&rsquo;s disease
por: Lakshmi Nayak, et al.
Publicado: (2008)

Pharmacological treatment of negative symptoms in schizophrenia: update and proposal of a clinical algorithm
por: Cerveri G, et al.
Publicado: (2019)

Current approaches to the treatment of Parkinson&rsquo;s disease
por: Joseph Jankovic, et al.
Publicado: (2008)

Update on ropinirole in the treatment of Parkinson&rsquo;s disease
por: Holly A Shill, et al.
Publicado: (2008)

Rivastigmine for the treatment of dementia associated with Parkinson&rsquo;s disease
por: Jennifer L Reingold, et al.
Publicado: (2007)

Update on the use of pramipexole in the treatment of Parkinson&rsquo;s disease
por: Radu Constantinescu
Publicado: (2008)

Optimal treatment of Alzheimer’s disease psychosis: challenges and solutions
por: Koppel J, et al.
Publicado: (2014)

Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments
por: Bargiotas P, et al.
Publicado: (2013)

The Effect of Type 2 Diabetes Mellitus on Neuropsychological Symptoms in Chinese Early Alzheimer’s Disease Population
por: Shi Q, et al.
Publicado: (2020)

Potential cellular and regenerative approaches for the treatment of Parkinson&rsquo;s disease
por: Emma L Lane, et al.
Publicado: (2008)

The emerging role of bexarotene in the treatment of Alzheimer’s disease: current evidence
por: Tousi B
Publicado: (2015)

Aripiprazole in the treatment of Huntington&rsquo;s disease: a case series
por: Andrea Ciammola, et al.
Publicado: (2008)